Navigation Links
Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
Date:7/8/2008

NEW YORK, July 8 /PRNewswire/ -- Concentric Pharma Advertising, Inc., a five-year-old independent agency and one of the fastest growing in the field, has been selected by biopharmaceutical company Neuromed for U.S. professional communications supporting a developmental once-daily medication for the treatment of chronic pain.

The full-service assignment will include a broad range of activities, including branding, launch planning, marketing strategy, the creation of graphics and other support materials, and all tactical execution

Neuromed is a biopharmaceutical company focused on developing new and improved pain therapies. Concentric will work with the company on its most advanced program, the development of an extended-release formulation of a potent and widely used pain reliever that currently requires several doses daily for optimal effectiveness. Founded in Canada in 1998, Neuromed conducts its clinical and commercial operations from an office in the Philadelphia region. The company's research and financial operations are based in Vancouver, British Columbia.

"After an extensive review of 14 agencies, we selected Concentric for this assignment on the strength of its strategic and creative approach to the launch of our product," said Sean Cunliffe, Chief Commercial Officer of Neuromed.

Mario Orlando, vice president of marketing, will oversee the account from the client side. Tim Campbell, director of client services at Concentric, will manage the business on the agency side. Spending has not been disclosed.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency established in 2002, helps clients meet diverse business objectives through innovative thinking, elegant creative strategies, results-oriented tactics, and flawless execution.

The company is one of the fastest growing agencies in the healthcare field. In the past year alone, Concentric has tripled its revenues, launched four brands, and doubled its staff to keep pace with a growing list of accounts. With professional and consumer assignments spanning the world, the agency's roster of clients includes Bayer HealthCare Pharmaceuticals Inc., Wyeth, Pfizer, Cobalt Laboratories, DePuy Spine, DePuy Mitek, Discovery Labs, and Mitsubishi Pharma USA.

Concentric is located at 71 West 23rd St, 9th floor, New York, NY 10010. Tel: 212-633-9700. For more information, visit http://www.concentric-rx.com or send an email to info@concentric-rx.com.

CONTACT: Julie Laitin (212) 286-2424 Cynthia Amorese (908) 665-8072

Email: jlaitin@julielaitin.com Email: camorese@comcast.net


'/>"/>
SOURCE Concentric Pharma Advertising, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. EH&E Launches Interactive Discussion Forum for Healthcare Environment of Care Professionals
2. IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year
3. First Complete Career Service for Life-Science Professionals
4. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
5. Online Career Site for Life Science Professionals Continues Growth
6. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
7. BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
10. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
11. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Vilnius, Lithuania, announced today that they have entered into a multiyear collaboration to ... provide CRISPR researchers with additional tools for gene editing across all applications. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):